Scrip
SkyePharma's asthma drug Flutiform could face US delay
10 June 2009
Asher Mullard
Please Login to read the full article.
10 June 2009
Asher Mullard
The
US FDA has given
SkyePharma a preliminary notice of some potential review issues for its combination asthma drug Flutiform (fluticasone propionate plus formoterol fumarate). Additional clinical work may be required to provide more data on dosing, potentially causing a delay to regulatory approval,...
Please Login to read the full article.
RELATED CONTENT
FEATURES
- Face-to-face: The FDA, Amgen, and its blockbuster biologic, denosumab
- Amarin focused on CV disease to pump new life into company
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
